Amlodipine Plus Botulinum Toxin for Focal Dystonia

NCT00015457 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

NIH

Sponsor class

Conditions

Focal Dystonia

Interventions

DRUG: Amlodipine plus Botulinum toxin

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)